New Covid Variant JN.1: All you need to know

  • Share this:
post-title

Frequently Asked Questions

JN.1 is a subvariant of the Omicron COVID-19 variant (BA.2.86.1). It was first detected in India in December 2023 and has since been found in other countries.
Early reports suggest JN.1 might be more contagious than other circulating variants. It is likely able to evade immune response and spread faster, even potentially infecting vaccinated individuals or those previously infected with COVID-19.
Symptoms of JN.1 are similar to other COVID-19 variants and can range from mild to severe. Common symptoms include: Fever, Cough, Fatigue, Sore throat, Headache, Muscle aches, Diarrhea and Difficulty breathing.
There is no current evidence that JN.1 causes more severe illness than other Omicron subvariants. However, as it is a new variant, more research is needed to fully understand its potential impact.
As with other COVID-19 variants, people at higher risk for severe illness include Older adults, People with underlying health conditions and Unvaccinated individuals.
While the exact effectiveness of vaccines against JN.1 is still under investigation, current vaccines are still expected to provide some protection against severe illness, hospitalization, and death, even if they may be less effective at preventing infection altogether.
The best ways to prevent JN.1 and other COVID-19 variants include: Getting vaccinated and boosted according to the latest recommendations, Wearing a well-fitting mask in indoor public settings and crowded areas, Maintaining physical distance from others, Practicing good hand hygiene & Staying home when sick.
Disclaimer: The information provided in this blog is intended for general knowledge and informational purposes only, and does not constitute medical advice. Always consult with a qualified healthcare professional for any medical concerns or before making any decisions about your health.